Efficacy of piperacillin/tazobactam as initial empiric therapy of febrile neutropenia in patients with hematologic malignancy.

被引：0
|
作者：
Bow, EJ
Noskin, GA
Schwarer, AP
Laverdiere, M
Vesole, DH
机构：
[1] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada
[2] Northwestern Univ, Sch Med, Chicago, IL USA
[3] Alfred Hosp, Melbourne, Vic, Australia
[4] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1000
引用
收藏
页码：281A / 281A
页数：1
相关论文
共 50 条
  • [1] Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients
    Sezgin, Gulay
    Acipayam, Can
    Ozkan, Ayse
    Bayram, Ibrahim
    Tanyeli, Atila
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (11) : 4549 - 4553
  • [2] MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS
    Sezgin, G.
    Acipayam, C.
    Ozkan, A.
    Kupeli, S.
    Bayram, I.
    Tanyeli, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 176 - 177
  • [3] Initial empiric therapy of febrile neutropenia with antibiotic monotherapy.: Piperacillin/tazobactam versus imipenem/cilastatin (1994-1996)
    Figuera, R
    Rivero, N
    Pajuelo, F
    Font, P
    Leyra, F
    de la Cámara, R
    Arranz, R
    Rañada, JMF
    MEDICINA CLINICA, 2001, 116 (16): : 610 - 611
  • [4] Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients
    Hamidah, A.
    Rizal, A. M.
    Nordiah, A. J.
    Jamal, R.
    SINGAPORE MEDICAL JOURNAL, 2008, 49 (01) : 26 - 30
  • [5] Piperacillin/Tazobactam Monotherapy Versus Piperacillin/Tazobactam Plus Amikacin as Initial Empirical Therapy for Febrile Neutropenia in Children with Acute Leukemia
    Zengin, Emine
    Sarper, Nazan
    Kilic, Suar Caki
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (04) : 311 - 320
  • [6] Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
    Najmul Karim
    Alamgir Kabir
    Manirul Islam
    Akhil Ranjan Biswas
    Mohammed Wasim
    Mahbubul Alam
    Nobendu Chowdhury
    Mohammed Nadimul Islam
    Tamanna Tabassum
    Mohammad Jahid Hasan
    The Egyptian Journal of Internal Medicine, 2022, 34
  • [7] Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia
    Weber, Nicholas
    Jackson, Kathryn
    McWhinney, Brett
    Ungerer, Jacobus
    Kennedy, Glen
    Lipman, Jeffrey
    Roberts, Jason A.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (07) : 503 - 508
  • [8] Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy - a real-life experience
    Karim, Najmul
    Kabir, Alamgir
    Islam, Manirul
    Biswas, Akhil Ranjan
    Wasim, Mohammed
    Alam, Mahbubul
    Chowdhury, Nobendu
    Islam, Mohammed Nadimul
    Tabassum, Tamanna
    Hasan, Mohammad Jahid
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01):
  • [9] Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
    Aslan, Muge
    Oz, Yasemin
    Akay, Meltem Olga
    Aksit, Filiz
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2014, 3
  • [10] Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia
    Yalcin, Cumali
    Ozkalemkas, Fahir
    Ozkocaman, Vildan
    Ersal, Tuba
    Pinar, Ibrahim Ethem
    Orhan, Bedrettin
    Candar, Omer
    Cubukcu, Sinem
    Koca, Tuba Gullu
    Akyol, Merve Nur
    Ada, Nevriye Gul
    Ozakin, Cuneyt
    Kazak, Esra
    Akalin, Halis
    Ali, Ridvan
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
12345